gicare Pharma Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Montreal QC Canada (2011)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2012
NCT01738425
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

trimebutine (3 trials)

Drugs in Phase 1 Trials (1)

gic-1002 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Diseases (Phase 2)

Visceral Pain (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2